Literature DB >> 16872247

An industry perspective on the Erice declaration and risk minimisation plans.

Simon Ingate, Deborah Tranter, Anjan Banerjee, Andrew Hobbs.   

Abstract

Mesh：

Year:  2006        PMID： 16872247     DOI： 10.2165/00002018-200629080-00010

Source DB:  PubMed          Journal:  Drug Saf        ISSN： 0114-5916            Impact factor:   5.606


× No keyword cloud information.
  3 in total

Review 1.  Drug safety and the media.

Authors:  Patrick C Waller; Stephen J W Evans; Keith Beard
Journal:  Br J Clin Pharmacol       Date:  2006-02       Impact factor: 4.335

2.  The Erice declaration : the critical role of communication in drug safety.

Authors:  Bruce Hugman
Journal:  Drug Saf       Date:  2006       Impact factor: 5.606

3.  Improving communication of drug risks to prevent patient injury: proceedings of a workshop.

Authors:  William H Campbell; Robert M Califf
Journal:  Pharmacoepidemiol Drug Saf       Date:  2003 Apr-May       Impact factor: 2.890
  3 in total
  1 in total

1.  Pharmaceutical company perspectives on current safety risk communications in Japan.

Authors:  Hisashi Urushihara; Gen Kobashi; Hideaki Masuda; Setsuko Taneichi; Michiko Yamamoto; Takeo Nakayama; Koji Kawakami; Tsutomu Matsuda; Kaori Ohta; Hiroki Sugimori
Journal:  Springerplus       Date:  2014-01-24
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.